ライフサイエンスコーパス: left ventricular fractional shortening

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 the heart with a significant decrease in the left ventricular fractional shortening.

2 rdiomyocyte cell size, and modestly impaired left ventricular fractional shortening.

3 f the FHC mice, with a significant change in left ventricular fractional shortening.

4 ar functions, such as peak filling rates and left ventricular fractional shortening.

5 for children who received doxorubicin alone (left ventricular fractional shortening: -0.82, 95% CI -1

6 end-diastolic z-scores (+4.2 vs. +4.2), and left ventricular fractional shortening (16% vs. 17%) at

7 ved cardiac contractile function measured as left ventricular fractional shortening (30 +/- 3% Galpha

8 rcoglycan-null mice showed an improvement in left ventricular fractional shortening (44.3 +/- 13.3% t

9 atrial dimension, left ventricular mass, and left ventricular fractional shortening (adjusted HR, 1.2

10 completion of doxorubicin chemotherapy, mean left ventricular fractional shortening and end-systolic

11 Vegetation size, left ventricular fractional shortening, and onset of aor

12 s showed dexrazoxane protection (p=0.04) for left ventricular fractional shortening at 5 years in gir

13 HF resulted in a decrease in left ventricular fractional shortening compared with con

14 iated with significant abnormalities in mean left ventricular fractional shortening, end-diastolic di

15 Doxorubicin decreased left ventricular fractional shortening from 57+/-2% to 4

16 ebrate rats with myocardial infarction (MI) (left ventricular fractional shortening (FS) = 24 +/- 1%;

17 om presentation to the echocardiogram before left ventricular fractional shortening (FS) improved to

18 iography showed a significant improvement of left ventricular fractional shortening in the minicircle

19 ngham Heart Study population, mildly reduced left ventricular fractional shortening (<30%) was more c

20 rements were abnormal at baseline (decreased left ventricular fractional shortening [LV FS] and contr

21 presence of congestive heart failure, lower left ventricular fractional shortening, or higher left v

22 wild-type mice, LPS significantly decreased left ventricular fractional shortening, velocity of circ

23 otoxin challenge in wild-type mice decreased left ventricular fractional shortening, velocity of circ

24 The mean left ventricular fractional shortening, wall thickness,

25 Using transthoracic echocardiography, left ventricular fractional shortening was 47+/-2%, 44+/

26 Left ventricular fractional shortening was quantified by

27 Left ventricular fractional shortening was significantly

28 icular fractional shortening Z score, higher left ventricular fractional shortening Z score during fo

29 sk of death or transplantation, as was lower left ventricular fractional shortening Z score during fo

30 familial cardiomyopathy, and lower baseline left ventricular fractional shortening Z score were asso

31 e older age, congestive heart failure, lower left ventricular fractional shortening Z score, and caus

32 Normalization was related to higher baseline left ventricular fractional shortening Z score, higher l

33 during follow-up, and greater improvement in left ventricular fractional shortening Z score.

34 ersus 78%, P<0.001), had less-depressed mean left ventricular fractional shortening z scores (-7.85+/

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。